ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic Radioisotopes Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-36G14063
Home | Market Reports | Health| Pharmacy
Global Therapeutic Radioisotopes Market Research Report 2023
BUY CHAPTERS

Global Therapeutic Radioisotopes Market Research Report 2025

Code: QYRE-Auto-36G14063
Report
September 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Lantheus
International Isotopes
Jubilant Radiopharma
Aurobindo Pharma
Mundipharma
China Isotope & Radiation

Therapeutic Radioisotopes Market Size

The global market for Therapeutic Radioisotopes was valued at US$ 2313 million in the year 2024 and is projected to reach a revised size of US$ 6108 million by 2031, growing at a CAGR of 15.1% during the forecast period.

Therapeutic Radioisotopes Market

Therapeutic Radioisotopes Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Therapeutic Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Radioisotopes.
The Therapeutic Radioisotopes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Radioisotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Radioisotopes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Therapeutic Radioisotopes Market Report

Report Metric Details
Report Name Therapeutic Radioisotopes Market
Accounted market size in year US$ 2313 million
Forecasted market size in 2031 US$ 6108 million
CAGR 15.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Radium-223
  • Lutetium-177
  • Iodine-131
  • Other
Segment by Application
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Therapeutic Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Therapeutic Radioisotopes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Therapeutic Radioisotopes Market growing?

Ans: The Therapeutic Radioisotopes Market witnessing a CAGR of 15.1% during the forecast period 2025-2031.

What is the Therapeutic Radioisotopes Market size in 2031?

Ans: The Therapeutic Radioisotopes Market size in 2031 will be US$ 6108 million.

Who are the main players in the Therapeutic Radioisotopes Market report?

Ans: The main players in the Therapeutic Radioisotopes Market are Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant Radiopharma, Lantheus, Aurobindo Pharma, International Isotopes, Mundipharma

What are the Application segmentation covered in the Therapeutic Radioisotopes Market report?

Ans: The Applications covered in the Therapeutic Radioisotopes Market report are Thyroid, Bone Metastasis, Lymphoma, Other

What are the Type segmentation covered in the Therapeutic Radioisotopes Market report?

Ans: The Types covered in the Therapeutic Radioisotopes Market report are Radium-223, Lutetium-177, Iodine-131, Other

Recommended Reports

Radioisotope Markets

Radiotherapy Devices

Cancer Therapy Trends

1 Therapeutic Radioisotopes Market Overview
1.1 Product Definition
1.2 Therapeutic Radioisotopes by Type
1.2.1 Global Therapeutic Radioisotopes Market Value Comparison by Type (2024 VS 2031)
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Therapeutic Radioisotopes by Application
1.3.1 Global Therapeutic Radioisotopes Market Value by Application (2024 VS 2031)
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Radioisotopes Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Radioisotopes Revenue 2020-2031
1.4.2 Global Therapeutic Radioisotopes Sales 2020-2031
1.4.3 Global Therapeutic Radioisotopes Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Therapeutic Radioisotopes Market Competition by Manufacturers
2.1 Global Therapeutic Radioisotopes Sales Market Share by Manufacturers (2020-2025)
2.2 Global Therapeutic Radioisotopes Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Therapeutic Radioisotopes Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Therapeutic Radioisotopes, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic Radioisotopes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic Radioisotopes, Product Type & Application
2.7 Global Key Manufacturers of Therapeutic Radioisotopes, Date of Enter into This Industry
2.8 Global Therapeutic Radioisotopes Market Competitive Situation and Trends
2.8.1 Global Therapeutic Radioisotopes Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Therapeutic Radioisotopes Players Market Share by Revenue
2.8.3 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Therapeutic Radioisotopes Market Scenario by Region
3.1 Global Therapeutic Radioisotopes Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Therapeutic Radioisotopes Sales by Region: 2020-2031
3.2.1 Global Therapeutic Radioisotopes Sales by Region: 2020-2025
3.2.2 Global Therapeutic Radioisotopes Sales by Region: 2026-2031
3.3 Global Therapeutic Radioisotopes Revenue by Region: 2020-2031
3.3.1 Global Therapeutic Radioisotopes Revenue by Region: 2020-2025
3.3.2 Global Therapeutic Radioisotopes Revenue by Region: 2026-2031
3.4 North America Therapeutic Radioisotopes Market Facts & Figures by Country
3.4.1 North America Therapeutic Radioisotopes Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Therapeutic Radioisotopes Sales by Country (2020-2031)
3.4.3 North America Therapeutic Radioisotopes Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Therapeutic Radioisotopes Market Facts & Figures by Country
3.5.1 Europe Therapeutic Radioisotopes Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Therapeutic Radioisotopes Sales by Country (2020-2031)
3.5.3 Europe Therapeutic Radioisotopes Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Radioisotopes Market Facts & Figures by Region
3.6.1 Asia Pacific Therapeutic Radioisotopes Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Therapeutic Radioisotopes Sales by Region (2020-2031)
3.6.3 Asia Pacific Therapeutic Radioisotopes Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Therapeutic Radioisotopes Market Facts & Figures by Country
3.7.1 Latin America Therapeutic Radioisotopes Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Therapeutic Radioisotopes Sales by Country (2020-2031)
3.7.3 Latin America Therapeutic Radioisotopes Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Therapeutic Radioisotopes Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Radioisotopes Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Therapeutic Radioisotopes Sales by Country (2020-2031)
3.8.3 Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Therapeutic Radioisotopes Sales by Type (2020-2031)
4.1.1 Global Therapeutic Radioisotopes Sales by Type (2020-2025)
4.1.2 Global Therapeutic Radioisotopes Sales by Type (2026-2031)
4.1.3 Global Therapeutic Radioisotopes Sales Market Share by Type (2020-2031)
4.2 Global Therapeutic Radioisotopes Revenue by Type (2020-2031)
4.2.1 Global Therapeutic Radioisotopes Revenue by Type (2020-2025)
4.2.2 Global Therapeutic Radioisotopes Revenue by Type (2026-2031)
4.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Type (2020-2031)
4.3 Global Therapeutic Radioisotopes Price by Type (2020-2031)
5 Segment by Application
5.1 Global Therapeutic Radioisotopes Sales by Application (2020-2031)
5.1.1 Global Therapeutic Radioisotopes Sales by Application (2020-2025)
5.1.2 Global Therapeutic Radioisotopes Sales by Application (2026-2031)
5.1.3 Global Therapeutic Radioisotopes Sales Market Share by Application (2020-2031)
5.2 Global Therapeutic Radioisotopes Revenue by Application (2020-2031)
5.2.1 Global Therapeutic Radioisotopes Revenue by Application (2020-2025)
5.2.2 Global Therapeutic Radioisotopes Revenue by Application (2026-2031)
5.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Application (2020-2031)
5.3 Global Therapeutic Radioisotopes Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Therapeutic Radioisotopes Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Therapeutic Radioisotopes Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 China Isotope & Radiation
6.3.1 China Isotope & Radiation Company Information
6.3.2 China Isotope & Radiation Description and Business Overview
6.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.3.4 China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio
6.3.5 China Isotope & Radiation Recent Developments/Updates
6.4 Dongcheng
6.4.1 Dongcheng Company Information
6.4.2 Dongcheng Description and Business Overview
6.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Dongcheng Therapeutic Radioisotopes Product Portfolio
6.4.5 Dongcheng Recent Developments/Updates
6.5 Q BioMed
6.5.1 Q BioMed Company Information
6.5.2 Q BioMed Description and Business Overview
6.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Q BioMed Therapeutic Radioisotopes Product Portfolio
6.5.5 Q BioMed Recent Developments/Updates
6.6 Curium Pharmaceuticals
6.6.1 Curium Pharmaceuticals Company Information
6.6.2 Curium Pharmaceuticals Description and Business Overview
6.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio
6.6.5 Curium Pharmaceuticals Recent Developments/Updates
6.7 Jubilant Radiopharma
6.7.1 Jubilant Radiopharma Company Information
6.7.2 Jubilant Radiopharma Description and Business Overview
6.7.3 Jubilant Radiopharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio
6.7.5 Jubilant Radiopharma Recent Developments/Updates
6.8 Lantheus
6.8.1 Lantheus Company Information
6.8.2 Lantheus Description and Business Overview
6.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lantheus Therapeutic Radioisotopes Product Portfolio
6.8.5 Lantheus Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Company Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 International Isotopes
6.10.1 International Isotopes Company Information
6.10.2 International Isotopes Description and Business Overview
6.10.3 International Isotopes Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.10.4 International Isotopes Therapeutic Radioisotopes Product Portfolio
6.10.5 International Isotopes Recent Developments/Updates
6.11 Mundipharma
6.11.1 Mundipharma Company Information
6.11.2 Mundipharma Description and Business Overview
6.11.3 Mundipharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mundipharma Therapeutic Radioisotopes Product Portfolio
6.11.5 Mundipharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Radioisotopes Industry Chain Analysis
7.2 Therapeutic Radioisotopes Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Radioisotopes Production Mode & Process Analysis
7.4 Therapeutic Radioisotopes Sales and Marketing
7.4.1 Therapeutic Radioisotopes Sales Channels
7.4.2 Therapeutic Radioisotopes Distributors
7.5 Therapeutic Radioisotopes Customer Analysis
8 Therapeutic Radioisotopes Market Dynamics
8.1 Therapeutic Radioisotopes Industry Trends
8.2 Therapeutic Radioisotopes Market Drivers
8.3 Therapeutic Radioisotopes Market Challenges
8.4 Therapeutic Radioisotopes Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Lantheus
International Isotopes
Jubilant Radiopharma
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
List of Tables
 Table 1. Global Therapeutic Radioisotopes Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Therapeutic Radioisotopes Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Therapeutic Radioisotopes Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Therapeutic Radioisotopes Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Therapeutic Radioisotopes Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Therapeutic Radioisotopes Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Therapeutic Radioisotopes Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Therapeutic Radioisotopes Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Therapeutic Radioisotopes, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Therapeutic Radioisotopes, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Therapeutic Radioisotopes, Product Type & Application
 Table 12. Global Key Manufacturers of Therapeutic Radioisotopes, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Therapeutic Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Radioisotopes as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Therapeutic Radioisotopes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Therapeutic Radioisotopes Sales by Region (2020-2025) & (K Units)
 Table 18. Global Therapeutic Radioisotopes Sales Market Share by Region (2020-2025)
 Table 19. Global Therapeutic Radioisotopes Sales by Region (2026-2031) & (K Units)
 Table 20. Global Therapeutic Radioisotopes Sales Market Share by Region (2026-2031)
 Table 21. Global Therapeutic Radioisotopes Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Therapeutic Radioisotopes Revenue Market Share by Region (2020-2025)
 Table 23. Global Therapeutic Radioisotopes Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Therapeutic Radioisotopes Revenue Market Share by Region (2026-2031)
 Table 25. North America Therapeutic Radioisotopes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Therapeutic Radioisotopes Sales by Country (2020-2025) & (K Units)
 Table 27. North America Therapeutic Radioisotopes Sales by Country (2026-2031) & (K Units)
 Table 28. North America Therapeutic Radioisotopes Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Therapeutic Radioisotopes Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Therapeutic Radioisotopes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Therapeutic Radioisotopes Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Therapeutic Radioisotopes Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Therapeutic Radioisotopes Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Therapeutic Radioisotopes Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Therapeutic Radioisotopes Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Therapeutic Radioisotopes Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Therapeutic Radioisotopes Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Therapeutic Radioisotopes Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Therapeutic Radioisotopes Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Therapeutic Radioisotopes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Therapeutic Radioisotopes Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Therapeutic Radioisotopes Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Therapeutic Radioisotopes Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Therapeutic Radioisotopes Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Therapeutic Radioisotopes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Therapeutic Radioisotopes Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Therapeutic Radioisotopes Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Therapeutic Radioisotopes Sales (K Units) by Type (2020-2025)
 Table 51. Global Therapeutic Radioisotopes Sales (K Units) by Type (2026-2031)
 Table 52. Global Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
 Table 53. Global Therapeutic Radioisotopes Sales Market Share by Type (2026-2031)
 Table 54. Global Therapeutic Radioisotopes Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Therapeutic Radioisotopes Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Therapeutic Radioisotopes Revenue Market Share by Type (2020-2025)
 Table 57. Global Therapeutic Radioisotopes Revenue Market Share by Type (2026-2031)
 Table 58. Global Therapeutic Radioisotopes Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Therapeutic Radioisotopes Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Therapeutic Radioisotopes Sales (K Units) by Application (2020-2025)
 Table 61. Global Therapeutic Radioisotopes Sales (K Units) by Application (2026-2031)
 Table 62. Global Therapeutic Radioisotopes Sales Market Share by Application (2020-2025)
 Table 63. Global Therapeutic Radioisotopes Sales Market Share by Application (2026-2031)
 Table 64. Global Therapeutic Radioisotopes Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Therapeutic Radioisotopes Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Therapeutic Radioisotopes Revenue Market Share by Application (2020-2025)
 Table 67. Global Therapeutic Radioisotopes Revenue Market Share by Application (2026-2031)
 Table 68. Global Therapeutic Radioisotopes Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Therapeutic Radioisotopes Price (USD/Unit) by Application (2026-2031)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer Therapeutic Radioisotopes Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Novartis Therapeutic Radioisotopes Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. China Isotope & Radiation Company Information
 Table 81. China Isotope & Radiation Description and Business Overview
 Table 82. China Isotope & Radiation Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. China Isotope & Radiation Therapeutic Radioisotopes Product
 Table 84. China Isotope & Radiation Recent Developments/Updates
 Table 85. Dongcheng Company Information
 Table 86. Dongcheng Description and Business Overview
 Table 87. Dongcheng Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Dongcheng Therapeutic Radioisotopes Product
 Table 89. Dongcheng Recent Developments/Updates
 Table 90. Q BioMed Company Information
 Table 91. Q BioMed Description and Business Overview
 Table 92. Q BioMed Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Q BioMed Therapeutic Radioisotopes Product
 Table 94. Q BioMed Recent Developments/Updates
 Table 95. Curium Pharmaceuticals Company Information
 Table 96. Curium Pharmaceuticals Description and Business Overview
 Table 97. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Curium Pharmaceuticals Therapeutic Radioisotopes Product
 Table 99. Curium Pharmaceuticals Recent Developments/Updates
 Table 100. Jubilant Radiopharma Company Information
 Table 101. Jubilant Radiopharma Description and Business Overview
 Table 102. Jubilant Radiopharma Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Jubilant Radiopharma Therapeutic Radioisotopes Product
 Table 104. Jubilant Radiopharma Recent Developments/Updates
 Table 105. Lantheus Company Information
 Table 106. Lantheus Description and Business Overview
 Table 107. Lantheus Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Lantheus Therapeutic Radioisotopes Product
 Table 109. Lantheus Recent Developments/Updates
 Table 110. Aurobindo Pharma Company Information
 Table 111. Aurobindo Pharma Description and Business Overview
 Table 112. Aurobindo Pharma Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Aurobindo Pharma Therapeutic Radioisotopes Product
 Table 114. Aurobindo Pharma Recent Developments/Updates
 Table 115. International Isotopes Company Information
 Table 116. International Isotopes Description and Business Overview
 Table 117. International Isotopes Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. International Isotopes Therapeutic Radioisotopes Product
 Table 119. International Isotopes Recent Developments/Updates
 Table 120. Mundipharma Company Information
 Table 121. Mundipharma Description and Business Overview
 Table 122. Mundipharma Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Mundipharma Therapeutic Radioisotopes Product
 Table 124. Mundipharma Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Therapeutic Radioisotopes Distributors List
 Table 128. Therapeutic Radioisotopes Customers List
 Table 129. Therapeutic Radioisotopes Market Trends
 Table 130. Therapeutic Radioisotopes Market Drivers
 Table 131. Therapeutic Radioisotopes Market Challenges
 Table 132. Therapeutic Radioisotopes Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Therapeutic Radioisotopes
 Figure 2. Global Therapeutic Radioisotopes Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Therapeutic Radioisotopes Market Share by Type: 2024 & 2031
 Figure 4. Radium-223 Product Picture
 Figure 5. Lutetium-177 Product Picture
 Figure 6. Iodine-131 Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Therapeutic Radioisotopes Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Therapeutic Radioisotopes Market Share by Application: 2024 & 2031
 Figure 10. Thyroid
 Figure 11. Bone Metastasis
 Figure 12. Lymphoma
 Figure 13. Other
 Figure 14. Global Therapeutic Radioisotopes Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Therapeutic Radioisotopes Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Therapeutic Radioisotopes Sales (2020-2031) & (K Units)
 Figure 17. Global Therapeutic Radioisotopes Average Price (USD/Unit) & (2020-2031)
 Figure 18. Therapeutic Radioisotopes Report Years Considered
 Figure 19. Therapeutic Radioisotopes Sales Share by Manufacturers in 2024
 Figure 20. Global Therapeutic Radioisotopes Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Therapeutic Radioisotopes Players: Market Share by Revenue in Therapeutic Radioisotopes in 2024
 Figure 22. Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Therapeutic Radioisotopes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Therapeutic Radioisotopes Sales Market Share by Country (2020-2031)
 Figure 25. North America Therapeutic Radioisotopes Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Therapeutic Radioisotopes Sales Market Share by Country (2020-2031)
 Figure 29. Europe Therapeutic Radioisotopes Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Therapeutic Radioisotopes Revenue Market Share by Region (2020-2031)
 Figure 37. China Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Therapeutic Radioisotopes Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Therapeutic Radioisotopes Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Therapeutic Radioisotopes Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Therapeutic Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Therapeutic Radioisotopes by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Therapeutic Radioisotopes by Type (2020-2031)
 Figure 59. Global Therapeutic Radioisotopes Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Therapeutic Radioisotopes by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Therapeutic Radioisotopes by Application (2020-2031)
 Figure 62. Global Therapeutic Radioisotopes Price (USD/Unit) by Application (2020-2031)
 Figure 63. Therapeutic Radioisotopes Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030
Nuclear Medicine Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Nuclear Medicines Market Insights Forecast to 2030
Radiopharmaceuticals for Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiopharmaceutical Therapy Market Research Report 2025
Therapeutic Nuclear Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2030
Global Diagnostic Radioisotopes Market Insights Forecast to 2030
Nuclear Drug for Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radioactive Therapeutic Drugs Market Research Report 2024
Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030
Global Radioisotopes in Medicine Market Research Report 2025
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025
Global Nuclear Medicine Market Research Report 2025
Global Medical Radioisotopes Market Research Report 2025
Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024
Global Radiopharmaceutical Market Research Report 2025
Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Radioisotope Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global SPECT and PET Radiopharmaceuticals Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions